Strategic Analysis Using SWOT-AHP: Beach Tourism in Sabah, Malaysia
Journal of the Asian Academy of Applied Business (JAAAB) · 09.12.2024 · 9 · 29-41
DOI: 10.51200/jaaab.7816 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Asian Academy of Applied Business (JAAAB), online erschienen am 09.12.2024. Verfasst von Chystal Kelly Ann Udian und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The popularity of beach tourism in Sabah has increased after the COVID-19 pandemic ended, this study aims to analyze what factors should be taken seriously to boost the competitiveness of the beach tourism industry in Sabah. Strategic analysis of beach tourism in Sabah, Malaysia, by utilizing the SWOT (Strengths, Weaknesses, Opportunities, and Threats) framework in combination with the Analytic Hierarchy Process (AHP). This is a descriptive research design. The problem itself contains many SWOT criteria, which have been reviewed in three phases with the assistance of industry external experts and AHP guidelines. This study introduces a hybrid SWOT-AHP strategic analysis in this area. The influencing elements have been assessed and rated to determine the most important factors on which the industry should focus.
Zitieren
APA
Udian, C. K. A., Madli, F., & Tamin, M. (2024). Strategic Analysis Using SWOT-AHP: Beach Tourism in Sabah, Malaysia. Journal of the Asian Academy of Applied Business (JAAAB), 9, 29-41. https://doi.org/10.51200/jaaab.7816
Vancouver
Udian CKA, Madli F, Tamin M. Strategic Analysis Using SWOT-AHP: Beach Tourism in Sabah, Malaysia. Journal of the Asian Academy of Applied Business (JAAAB). 2024;9:29-41. doi:10.51200/jaaab.7816
BibTeX
@article{Udian2024,
author = {Udian, Chystal Kelly Ann and Madli, Faerozh and Tamin, Masran},
title = {Strategic Analysis Using SWOT-AHP: Beach Tourism in Sabah, Malaysia},
journal = {Journal of the Asian Academy of Applied Business (JAAAB)},
year = {2024},
volume = {9},
pages = {29--41},
doi = {10.51200/jaaab.7816}
}
EUVIMED